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ABSTRACT  
Objective: This study aims to formulate meniran extract into polymeric nanoparticles. Better stability of active substances in formulas compared to 
unformulated extracts is expected to increase immunomodulatory activity. 
Methods: Nanoparticles were formulated using ionic gelation method with chitosan and tripolyphosphate polymers. Optimize the mixture of 
nanoparticles using simplex lattice design (SLD) with the help of Design-Expert (DX) software. Evaluation of particle size and potential zeta using 
dynamic light scattering (DLS). Interactions between components were analyzed using Fourier transform infrared spectrophotometry-attenuated 
total reflectance (FTIR-ATR) and morphology of the lyophilization results observed using scanning electron microscopy (SEM). Immunomodulatory 
tests using the latex assay method. The parameters tested included phagocytosis index, phagocytic activity, and nitric oxide secretion.  
Results: The optimum mixture of the formulation process was obtained in the composition of chitosan 0.270 %, extract 0.626 %, and 
tripolyphosphate 0.074 % with desirability value of 0.841. Optimal response with particle size 434.7±3.90 d. nm, polydispersity index 0.285±0.03 
and entrapment efficiency 62.98±0.65 %. The zeta potential value in the optimum formula is 11.9±0.1 mV with a positive charge. Phagocytosis index 
and phagocytic activity of nanoparticles differed significantly (p<0.05) compared with unformulated extracts. 
Conclusion: Meniran extract was successfully formulated into polymeric nanoparticles using chitosan-tripolyphosphate polymer. The developed 
nanoparticles have the immunomodulatory activity that is better than unformulated extract. 
Keywords: Phyllanthus niruri L., polyphenols, Chitosan nanoparticles, Immunomodulatory, Phagocytosis 




Phyllanthus niruri L. with the local name meniran (Indonesia) is one 
of the natural ingredients that have pharmacological activities. The 
herbal ingredients of this plant based on clinical trials have 
immunomodulatory activity [1]. The extract has been reported to 
increase specific and non-specific immune responses and is useful in 
immunodeficiency conditions [2, 3]. Meniran extract has been 
shown to increase macrophage phagocytic activity and nitric oxide 
production [4]. Many polyphenol compounds have been reported to 
have positive pharmacological effects [5–7]. In this case, the primary 
compound responsible for increasing the immune system is 
polyphenols, especially flavonoids [8]. 
Oral administration is widely used in immunomodulatory therapy 
because of its comfort and superiority. However, poor solubility and 
risk of first pass metabolism cause problems in bioavailability so 
that the immunomodulatory effects are not optimal [9, 10]. The 
problem of instability and solubility of a drug molecule can be solved 
using biodegradable polymer nanoparticle technology [11]. 
Nanotechnology applications can be a solution for solubility, 
bioavailability and open new opportunities to develop nano-delivery 
systems for active ingredients based on natural materials [12, 13]. 
Drug delivery systems such as polymeric nanoparticles, microparticles, 
and emulsions have been applied to improve stability, protect bioactive 
components from metabolism and enzymatic degradation due to 
temperature or light [14]. One of the polymers that are widely used in 
drug delivery systems based on nanoparticles is chitosan [15]. Chitosan 
is biodegradable, biocompatible, and easily processed in various forms 
[16, 17]. Negatively charged tripolyphosphate compounds (TPP) are 
used in the formation of nanoparticles using positively charged chitosan. 
In the formulation, chitosan will be stabilized by TPP through 
intramolecular hydrogen bonds [18, 19]. 
Research results related to the development of polyphenol delivery 
systems from various plant extracts have been widely reported [20, 
21]. However, as far as our search and knowledge, chitosan-TPP 
formulations to deliver meniran extracts and immunomodulatory 
assay have never been reported. This study aims to formulate 
chitosan, TPP, and meniran extract into polymeric nanoparticles 
using ionic gelation method. Characterization includes particle size 
diameter, polydispersity index, zeta potential, and entrapment 
efficiency. Profiling using Fourier Transform Infrared 
Spectrophotometry-Attenuated Total Reflectance (FTIR-ATR) and 
scanning electron microscopy (SEM). Immunomodulatory activity 
was evaluated from phagocytosis index, phagocytic activity, and 
nitric oxide secretion. Furthermore, it is expected to obtained 
nanoparticles-based meniran extract immunomodulatory product. 
MATERIALS AND METHODS 
Chemicals and sampels 
Standard quercetin, chitosan, tripolyphosphate, and latex beads 
polystyrene were obtained from Sigma-Aldrich (St. Louis, MO, USA). 
Glacial acetic acid, giemsa, ethanol, and methanol were purchased 
from Merck (Darmstadt, Germany). Meniran (Phyllanthus niruri L.) 
were purchased from Merapi Farma (Sleman, Indonesia). 
Preparation of chitosan nanoparticle loaded the meniran extract 
Characterization of Phyllanthus niruri samples with specimen 
numbers of HS/PN/0003/17 stored in the Pharmacognosy 
Laboratory, Pharmaceutical Biology, STIKES Aisyiyah Palembang. 
Meniran extract (ME) was produced using the maceration method 
with 70 % ethanol solvent. Nanoparticle formulation uses ionic 
gelation method with modification [22,23]. Chitosan solution was 
obtained by dissolving chitosan powder in acetic acid (1 %, v/v). 
Nanoparticles were produced by mixing extract solution into 
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chitosan and adding TPP solution drop by drop. The nanoparticles 
formulated will then be abbreviated as meniran extract 
nanoparticles (ME-NPs). 
Optimization design using simplex lattice design 
Optimization in this formulation uses a design of experimental (DoE) 
approach. The design and processing of data using Design-Expert 
software (Stat-Ease Inc., Minneapolis, MN, USA). The design chosen 
in DoE is part of the simplex lattice design (SLD) of mixture designs. 
The design uses independent variables chitosan (A; %), ME (B; %), 
and TPP (C; %). In the modeling, three responses were selected to be 
evaluated, namely particle size (Y1), polydispersity index (Y2), and 
entrapment efficiency (Y3
 
). The composition of the mixture of 
ingredients from each experiment is presented in table 1. 
Table 1: Composition of mixtures in the simplex lattice design and experimental results 







Particle size (d. nm) 
: Y2*
Polidispersity index (PDI) 
: Y3*
Entrapment efficiency (%) 
: 
1 0.270 0.680 0.020 530.9 0.464 50.95 
2 0.360 0.590 0.020 679.8 0.507 52.84 
3 0.360 0.590 0.020 691.5 0.513 52.02 
4 0.315 0.590 0.065 485.1 0.329 61.23 
5 0.270 0.635 0.065 391.9 0.261 62.61 
6 0.285 0.650 0.035 552.2 0.341 54.89 
7 0.285 0.605 0.080 435.0 0.268 64.06 
8 0.330 0.605 0.035 632.3 0.359 53.48 
9 0.270 0.590 0.110 704.2 0.424 68.77 
10 0.300 0.620 0.050 573.4 0.428 57.63 
11 0.315 0.635 0.020 642.1 0.442 52.52 
12 0.270 0.680 0.020 539.0 0.467 51.45 
13 0.315 0.635 0.020 770.3 0.393 52.83 
14 0.270 0.590 0.110 729.3 0.381 67.42 
15 0.315 0.590 0.065 465.2 0.421 61.92 
*Data from each response is presented in mean (n=3) 
 
Determination of particle size, zeta potential, and 
electrophoretic mobility 
The particle size diameter, polydispersity index (PDI), zeta potential, 
and electrophoresis mobility were measured using a dynamic light 
scattering (DLS), namely Zetasizer Nano ZSP (Malvern Panalytical, 
UK). The data obtained as output from the Zetasizer 7.12 series 
software (Malvern Panalytical, UK). Measurements were adapted 
from previous studies with slight modifications [18, 24]. 
Determination of total flavonoid content (TFC) 
Flavonoid content was determined using quercetin standard. 
Measurements by spectrophotometric method using aluminum 
chloride reagent with sufficient modification [25, 26]. Instrumentation 
used by Hitachi U-2900 (Hitachi, Japan) spectrophotometer. 
Determination of entrapment efficiency (EE) 
Nanoparticles were centrifuged at a speed of 15000 rpm at 24 °C for 
30 min. The supernatant obtained was determined by TFC. 
Percentage of EE calculations using the formula:  
Entrapment efficiency (EE, %)
=  
(Total TFC in extract −  Total TFC in the supernatant)
Total TFC in extract
 X 100 % 
FTIR-ATR spectroscopy 
The interaction between nanoparticle-making materials was observed 
qualitatively using FTIR-ATR. The analysis was carried out on ME-NPs 
optimum formula, chitosan, TPP, and ME. The Nicolet iS5 FTIR-ATR 
spectrometer equipped with Omnic (Thermo Scientific, USA) software 
was used in the functional group characterization. The analysis was 
carried out at 4000 to 500 cm-1 with a resolution of 4 cm-1
Morphology of prepared using SEM 
. 
ME-NPs solution was made in powder form (lyophilization). 
Morphology of the sample was observed using SEM with a JSM-6510 
(Jeol, Tokyo, Japan). 
Stability test of nanoparticles 
The test was carried out by storing nanoparticles at a temperature of 
25 to 30 °C for seven days. Nanoparticle samples measured particle 
diameter, PDI, zeta potential, and electrophoretic mobility on days 1, 
3, and 7. 
Experimental animals 
The immunomodulatory assay using the latex assay method [4,9,27]. 
The animals used were Sprague Dawley rats with ethical clearance 
number 00150/04/lPPT/XII/2017. Experimental animals were 
adapted to the laboratory environment for one week. Rats grouping 
for immunomodulatory activity was done by dividing rats into five 
groups (water, CMC, ME, ME-NPs, and nanoparticles without extract 
(NPs-B)). Rats were treated according to their respective groups for 
seven days. 
Macrophage isolation and culture 
The peritoneal sheath was opened and cleaned using 70 % 
alcohol. Macrophage cells were taken with the help of RPMI-
1640 medium in the peritoneal cavity. As much as 5 ml of 
macrophage fluid obtained was collected and put into a 
refrigerator. Macrophage liquid was centrifuged at 1200 rpm, 4 
°C for 10 min. The supernatant was discarded, then 1 ml of 
complete RPMI was added to the pellet obtained. The amount 
obtained was calculated using a hemocytometer, then 
resuspended with a complete RPMI medium to obtain a cell 
suspension with a cell density of 2.5 x 106
The cell suspension was grown in microplate 24 wells with a volume 
of each well 200 µl (5 x 10
/ml. 
5/ml) and given a slipcover. The cell 
suspension was incubated at 37 °C for 30 min in a 5 % CO2 
incubator. Furthermore, complete RPMI was added to 1 ml/well and 
incubated for 2 h. Subsequently, the media was discarded and added 
1 ml complete RPMI/ well each time, incubated for 24 h in a 5 % CO2
Assay of macrophage phagocytosis 
 
incubator and continued with activity test and phagocytosis index 
using the latex method in vitro. 
Non-specific phagocytosis assay was carried out using 20 µl latex 
beads (3 d. µm) suspended in 300 µl serum. The latex suspension is 
added to a well of 300 µl/well (5 x 106 latex), incubating for 60 min 
at 37°C. Then washing the suspension using PBS solution 2-3 times. 
Staining using giemsa 20 % with 30 min soaking. Calculation of the 
number of activated macrophages and the number of latex 
phagocytes in 100 macrophages. Every 100 cells of macrophages 
that phagocytize latex particles were calculated using a microscope. 
White latex and purple macrophages on observations using an 
inverted microscope (Zeiss, Olympus). 
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Determination of nitric oxide (NO) 
The method of determining NO secretion using Griess reaction with 
slight modification. Samples were prepared after culturing for 24 h. 
A total of 100 µl of samples and standard nitrite are included in the 
well. Furthermore, 100 µl Griess solution (1 % sulfanilamide, 0.1 % 
naphthyl ethylenediamine in 5 % phosphoric acid) was added to 
each well-containing samples and standards. Microtiter plates were 
left at room temperature for 15 min until color changes occur. 
Absorbance measurements using a plate reader were carried out at 
a wavelength range of 520-590 nm. The levels of nitric oxide can be 
calculated by extrapolating data from standard curves using 
standard sodium nitrite. 
Statistical analysis 
Models in optimization were analyzed using Design-Expert software 
(Stat-Ease Inc., Minneapolis, MN, USA). All data are presented as 
means±SD. The statistical analysis of the experimental results was 
performed using the SPSS software (SPSS Inc, Chicago, IL, USA). A p-
value<0.05 was considered significant to compare 
immunomodulatory assay results. 
RESULTS AND DISCUSSION 
Optimization studies using the design of experiment (DoE) 
approach 
Complete data on experimental results are presented in table 1. Data 
related to response results from 15 experiments scattered around 
the diagonal line on the normal plot of residuals (fig. 1-A, 1-B, and 1-
C). This result indicates that the data is normally distributed and 
meets the requirements for the analysis of variance (ANOVA) test. 
Based on statistical analysis, the equation models of the three 
responses (Y1, Y2, and Y3
 
) can be used to predict the optimum 
mixture of the nanoparticle formulation process. Models of all three 
responses showed significant results (p<0.05) and the lack of fit was 
not significant (p>0.05). Particle size and polydispersity index as the 
first and second responses have quadratic models. The response of 
entrapment efficiency was obtained by a special quartic model. 
Table 2: Analysis of variance from the equation model obtained 
Parameter Y1 Y:  Particle size (d. nm) 2 Y:  Polydispersity index (PDI) 3:  Entrapment efficiency (%) 
Standard deviation 48.27 0.0491 0.5955 
Mean 588.15 0.3999 57.64 
CV (%) 8.21 12.27 1.03 
Press 50380.37 0.0452 38.33 
Value R 0.8869 2 0.7412 0.9960 
Adjusted R 0.8240 2 0.5974 0.9906 
Predicted R 0.7283 2 0.4598 0.9275 
Adequate precision 10.5377 7.3933 36.6193 
 
Predicted vs. actual curves are used to detect values, or groups of values, 
that are not easily predicted by the model. The predictive and actual 
values of particle size are not much different (fig. 1-D, 1-E, 1-F) with the 
difference in adjusted R2 and predicted R2
 
 values less than 0.2 (table 2). 
These results indicate that there is no significant difference between the 
observed data and predictive data from the suggested model. 
 
Fig. 1: Normal plot and predicted vs. actual plot 
 
Based on the regression equation in table 3 shows a description 
of the influence of each material component as a factor in the 
response of the formed particle size. Each constituent 
component of nanoparticles, namely chitosan (A), ME (B), and 
TPP (C) affects the increase in particle size, PDI, and EE 
produced. 
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Table 3: Type of model and equation of response 
Response Transform Model Equation 
Y1 None : Particle size Quadratic Y1 = 687.52A+536.08B+702.77C+474.72AB–843.31AC–842.68BC 
Y2: None Polydispersity index Quadratic Y2 
Y
= 0.503A+0.463B+0.395C–0.235AB–0.290AC–0.622BC 







Response of particle size (Y1
The interaction of chitosan-ME (AB) can increase the diameter of the 
particle size. The interaction of chitosan with TPP (AC) and ME 
interaction with TPP (BC) can reduce particle size. Chitosan as the 
main polymer will interact and bind the active compound from the 
extract in a certain amount so that the interaction of chitosan-ME 
(AB) will increase the particle size. TPP acts as a crosslinking agent, 
in this case, its interaction with chitosan and extracts has a role in 
forming particles of a certain size [28,29]. Experiments at run 2, 3, 8, 
9, 13, and 14 resulted in an average particle size diameter above 600 
nm. Particle size that is too large is strongly influenced by the 
interaction of extracts and TPP. Experiments at run 5 and 12 proved 
that the same chitosan concentration (0.270%) gave different 
particle sizes at different ME (0.635% and 0.680%) and TPP (0.06% 




Fig. 2: Contour plot (A, B, and C)and 3D surface plot (D, E, and F) 
 
The relationship between the dependent variable (Y1
Response of polydispersity index (Y
) and the 
independent variable or factor (A, B, C) can be seen in the contour 
plot (fig. 2-A, 2-B, 2-C) and 3D surface plot (fig. 2-D, 2-E, 2-F). High 
chitosan concentrations tend to be obtained with larger particle 
sizes. However, low concentrations of chitosan do not always 
produce smaller particles. TPP in too low concentration tends to 
increase particle size diameter. Increased extract concentration will 
affect particle size but gives a more stable effect compared to 
chitosan and TPP. Chitosan at low concentrations can form smaller 
and more stable nanoparticles [30]. Adding a small amount of TPP 
with a large concentration of chitosan will cause the formation of 
micro-sized particles quickly. This is indicated by the presence of a 
suspension mist in solution. 
2
The concentration of chitosan (A), ME (B), and TPP (C) can affect the 
increase in PDI from the resulting nanoparticle suspension. The 
highest PDI value (0.507) was generated in run 2. The experiment 
that was run 5 in SLD produced the lowest PDI, which was 0.261. 
Composition at run 2 and 5 (table 1) proves the effect of each 
component on the PDI obtained. Based on the contour plot (fig. 2-B) 
and 3D surface plot (fig. 2-E), the higher the concentration of 
chitosan will be obtained by the high PDI value. The high TPP 
concentration in its interaction with other components can reduce 
the PDI. Low PE concentrations in interaction with low chitosan 
concentrations and high concentration TPP tend to decrease PDI. 
The most important characteristics in the nanoparticle system are 
the size and distribution of particles. Particle size distribution is 
expressed in the polydispersity index in the range between 0-1. 
Homogeneous dispersion is indicated by the PDI value close to 0, 
while PDI more than 0.5 indicates high heterogeneity. 
) 
Response of entrapment efficiency (Y3
Entrapment efficiency is an essential parameter in the development 
of material based on natural drug delivery systems [21, 23]. The 
percentage of entrapment efficiency can provide an overview of the 
effectiveness of active binding compounds by polymer complexes in 
the nanoparticle system. The model obtained for the absorption 
efficiency response (Y
) 
3) is special quartic. The existence of an 
interaction variable of three ABC factors, with one quadratic 
component, becomes a special quartic with a square difference in 
the Y1 and Y2
Based on the regression equation (table 3), contour plot (fig. 2-C), 
and 3D surface plot (fig. 2-F), the interaction between the three 
components with a larger chitosan composition (A
 responses. 
2BC) gives a 
decrease in the percentage of entrapment efficiency. The percentage 
of entrapment efficiency will increase in low concentration chitosan, 
low concentration extracts, and high concentration TPP. 
Experiments at run 1 and 9 (table 1) proved that the concentration 
Martien et al. 
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of extract and TPP greatly influenced the percentage of adsorption 
efficiency at constant chitosan concentrations. 
Optimum formula and verification 
Particle size and entrapment efficiency are the main parameters in 
the development of extract-based polyphenol compounds using this 
polymeric nanoparticle model. The priority value for both responses 
is given the highest. Absorption efficiency is given a maximum target 
in the hope that high active compounds (flavonoids) will be 
obtained. The model obtained from the SLD experiment was used to 
predict the optimum mixture composition. The optimum component 
mixture consisted of chitosan concentration as the primary polymer 
0.270 %, ME 0.626 %, and TPP as the crosslinking agent 0.074 %. 
The desirability value is used as an important indicator in 
determining the optimum mixture. The composition of the mixture 
with desirability value 0.841 will give a particle size diameter of 
433.2 nm, a polydispersity index of 0.273 and a total flavonoid 
entrapment efficiency of 64.06 % (table 4). The intersection point of 
the optimal formula results can be seen in the contour plot 
(yellowish-orange area) with a desirability value 0.841 (fig. 3). 
The particle size diameter in the optimum formula was 434.7±3.90 
nm, theoretically included in the 95 % range of verification CI 
(343.8-520.4 nm) and from 95 % range of PI (291.6-572, 5 nm) well 
verified. PDI and EE values were also well verified, in the range of 
0.183 to 0.362 and 62.61 to 65.41 % (based on 95 % CI range). 
Based on one sample t-test, particle size, PDI, and entrapment 
efficiency of the optimum formula there was no significant 





Table 4: Verification range from CI and PI 
Response Predicted Observation 95 % CI * 95 % PI 
Low High Low High 
Y1 432.1 : Particle size (d. nm) 434.7±3.90 343.8 520.4 291.6 572.5 
Y2: 0.273 Polydispersity index (PDI) 0.285±0.03 0.183 0.362 0.130 0.415 
Y3: 64.01 Entrapment efficiency (%) 62.98±0.40 62.61 65.41 61.99 66.03 
*mean (n=6)±standard deviation (SD) 
 
Zeta potential and electrophoretic mobility 
In the nanoparticle formulation, high zeta potential is targeted 
because it relates to stability and effectiveness in drug delivery 
systems [31]. Small particles with high zeta potential represent high 
Brownian motion. Therefore, aggregation is not formed to increase 
stability in the dispersion system. When zeta potential is low, the 
attraction is greater than the repulsion force which causes 
dispersion to break, and particle flocculation occurs. The zeta 
potential value produced is 11.9±0.1 mV with a positive charge. 
Although the zeta potential produced is relatively small, the 
nanoparticles are likely to be stabilized by the TPP layer through 
steric stabilization. Although zeta potential is only 20 mV or much 
lower but has steric stability, it can provide sufficient stabilization 
[32]. Steric stabilization involves the adsorption of polymers on the 
surface of the particles. Coatings adsorbed by polymers such as TPP 
will act as a barrier on the surface of the particles. That barrier will 
prevent particles from returning together because of the van der 
Waals attraction. 
Electrophoretic mobility parameters, solids move in a liquid phase 
because there is an electric field applied to the system. As a result of 
this electric field, the particles will move, and their movement speed 
reaches the maximum when the electric force is proportional to the 
style of the friction. Electrophoresis phenomenon is characterized by 
electrophoretic mobility, which is the speed of unity of electric field 
strength (µmcm/Vs). 
Characterization using FTIR-ATR 
FTIR-ATR spectra are analyzed based on vibrations in the functional 
groups of each component material. The spectral patterns of the 
analysis results on chitosan, ME, TPP, and ME-NPs materials are 
shown in fig. 4. The spectra of the extract are strongly influenced by 
the specific and specific structure of the flavonoid and polyphenolic 
groups. Chitosan shows several typical peaks in the IR spectra, and 
namely, absorption widened and overlap between stretching 
vibrations of O-H and N-H at wave numbers 3423 cm-1. There is 
stretch vibration absorption C=O at wave number 1654 cm-1 and NH 
bending vibration at wave number 1596 cm-1. The peak is a typical 
peak that marks the presence of amine and hydroxy groups in 
chitosan. There is also a stretching vibration of C-O-C from the 
glycoside bond at wave number 1079 cm-1
The extract used in this study is acidic with a pH of 4.83. The 
dominant polyphenol content causes the extract to be acidic. It also 
causes extracts to tend to be negatively charged. The ME spectra 
pattern (fig. 4-C) has a peak in the area of 3400 to 3200 cm
. The chitosan spectra of 
the measurement results are similar to some existing literature [33]. 
-1 
indicating the presence of an-OH group. The absorption peak at 
2923 cm-1 marks the presence of a C-H group. The presence of 
aromatic C=C bonds is indicated by a vibration peak in the 1456 cm-1
The interaction between components is estimated not only between 
chitosan and TPP. The positively charged group of chitosan can 
interact first with the negatively charged group of the extract. The 
interaction between constituent components is shown by the shift of 
several spectral peaks after being analyzed in the form of 




experienced a shift and widened. In addition to the new peak 
spectra, there is also a shift in the peak spectra of functional groups 
of each component. The peak of the spectra in the 1034 cm-1
Morfologi using SEM 
 area 
indicates the presence of P=O groups from TPP. 
The morphological evaluation was carried out on the powder 
produced by drying the ME-NPs (lyophilized) using SEM. From the 
evaporation process, a gel-like texture with a thicker texture (gel 
aggregate) is obtained. This condition, caused by polyphenol 
compounds which dissolve in ethanol binds to chitosan so that the 
Martien et al. 
Int J App Pharm, Vol 11, Issue 2, 2019, 50-58 
 
55 
interaction with acetic acid becomes weak and aggregate gel is 
formed when the solvent evaporation process. Gel aggregates will 
become solid sheets with a drying process under high pressure. ME-
NPs sheets obtained are then made into fine powder. 
 
 
Fig. 4: FTIR-ATR spectra, chitosan (A), TPP (B), ME (C), and ME-NPs (D) 
 
 
Fig. 5: Morphology of lyophilized powder particles from ME-NPs using SEM 
 
Particle morphology of evaluation results with SEM is presented in 
the fig. 5. The particle morphology shown in the fig. is the layers that 
are stacked instead of spherical. Morphological conditions of 
spherical nanoparticles can be taken in liquid form (nanoparticle 
suspension). Therefore TEM instrumentation will be more precise in 
providing a general description. However, this study was not 
conducted because ME-NPs powder material will be given to 
experimental animals in the immunomodulatory assay. 
Nanoparticle stability assay 
Stability is a condition that is good within certain limits throughout 
storage and uses or can be interpreted as the same characteristics as 
Martien et al. 
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when it was first made. The optimum formula was stored at room 
temperature and measured on days 1, 3, and 7. Physical stability was 
observed from changes in particle size, PDI, and zeta potential values 
from the sample. 
 
Tabel 5: Physical measurement of nanoparticles 
Time (D) Particle size* Polydispersity index(d. nm) Zeta potential* * Electrophoretic mobility(mV) * (µmcm/Vs) 
1 428.9±17.9 0.307±0.021 11.9±0.1 0.933±0.007 
3 402.0±2.4 0.276±0.003 12.1±0.8 0.947±0.058 
7 393.2±9.2 0.256±0.012 13.4±0.6 1.050±0.044 
*(n=3) mean±SD 
 
Particle size has decreased on days 3 and 7 (table 5). The measured 
particles are probably particles that are still floating in the system. 
Small particles that combine to form agglomerates and tend to be 
unstable will form deposits at the bottom of the system and become 
undetectable at particle size measurements. The results of this study 
are following the theory of the effect of temperature on the size of 
chitosan nanoparticles which give results that at low-temperature 
storage of 10 to 25 °C the particle size is still relatively small [34]. 
Storage of chitosan nanoparticle solutions at temperature variations 
of-10, 5, and 25 °C. Temperature storage of-10 °C is ignored because 
of the stabilization of the nanoparticle solution. Significant particle 
size increases occurred at storage temperatures of 5 °C and 25 °C 
which were observed on days 15 and 7. 
The PDI values observed on days 3 and 7 showed that nanoparticles 
still showed good homogeneity. Besides, the polydispersity index 
measured still meets the 95 % CI range of the values required by 
Design-Expert software. Electrophoretic mobility describes the 
speed of movement of charged particles in the system. The higher 
the value of electrophoretic mobility indicates that the faster the 
particles move. This causes the system to be more stable because 
there is no agglomeration. The ME-NPs is still stable on days 3 and 7 
with storage conditions at room temperature. 
Macrofage phagocytosis  
Macrophage activity describes the percentage of active macrophage 
cells that can phagocytose latex (fig. 6). Visually from phagocytosis 
assay preparations, macrophage cells in ME-NPs appear to eat more 
of the latex granules (fig. 6-C). Phagocytosis index describes the 
ability of macrophage cells to be active in phagocytosis of latex (fig. 
7-A). The phagocytic index is higher with the increasing number of 
phagocytic latex. ME-NPs treatment group had the highest 
phagocytosis index compared to other treatment groups. The water 
treatment group as a normal group had a phagocytosis index value 
of 1.43±0.07 and not much different from the CMC treatment group, 
which was 1.22±0.09. 
The ME-NPs group showed the highest phagocytosis index 
compared to other groups, which were 3.04±0.15. The NPs-B 
(nanoparticles without extract) treatment group had a lower 
phagocytosis index value compared with ME-NPs, which was 
1.61±0.09. Meniran herbal extracts that were not formulated had a 
phagocytosis index of 2.26±0.01. The results of the statistical 
analysis of the phagocytosis index of macrophages showed that 
there were significant differences between ME-NPs groups with all 
treatment groups (p<0.05). 
 
 
Fig. 6: Phagocytosis of macrophage cells, treatment with water 
(A), meniran extract (B), ME-NPs (C), and NPs-B (D) 
 
The activity of macrophages in each treatment group is shown in fig. 
7-B. ME-NPs showed macrophage phagocytosis activity of 
89.00±3.61 % and unformulated extract (ME) of 79.89±0.93 %. 
Phagocytosis activity of ME-NPs also showed results that were 
significantly different from other groups (p<0.05). The higher the 
percentage of macrophage cells that are active from a total of 100 




Fig. 7: Phagocytosis index (A) and phagocytosis activity (B) (n=6) 
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Nitric oxide (NO) 
Macrophages can destroy antigens by respiratory burst and produce 
ROS such as superoxide, hydrogen peroxidase and nitric oxide (NO). 
Nitric oxide is a powerful microbicidal agent against intracellular 
microorganisms. Nitric oxide is a parameter that shows the 
activation of macrophage cells [4,10]. Nitric oxide was measured 
from the supernatant culture of peritoneal macrophages (fig. 8). 
 
 
Fig. 8: NO secretion from each treatment group (n=6) 
 
ME-NPs were not significantly different from extract (p>0.05) but 
were significantly different from NPs-B (p<0.05). Improved 
macrophage performance is accompanied by increased 
phagocytosis. Active phagocytes (macrophages and neutrophils) will 
secrete NO. Nitric oxide can attack the cells that produce it and the 
cells that surround it to enable a decrease in NO levels despite high 
activity [10]. 
Immunomodulatory activity 
Meniran herbal extract formulated in the form of polymeric 
nanoparticles has a higher immunomodulatory activity than 
unformulated extract. The stability of active substances reaching the 
systemic circulation becomes an essential factor in increasing the 
activity of immunomodulators. Also, optimal activity is influenced by 
the absorption and release of active substances into the systemic 
circulation. Flavonoids have low water solubility even in the form of 
glycosides. Flavonoids have low bioavailability and are easily 
modified due to environmental factors such as temperature, pH, and 
light. The mechanism of the absorption of flavonoids in the 
gastrointestinal causes a small number of flavonoids absorbed in the 
small intestine [35]. Flavonoids can be modified into other forms 
before reaching the absorption area due to degradation by 
microorganisms or enzymes in the intestine [36]. 
Nano-sized drug delivery systems significantly affect the absorption 
profile of active substances. Polymeric nanoparticles can increase 
solubility, bioavailability, efficacy, reduce doses, and increase 
absorption of herbal medicines [37]. Particle size, morphology, and 
character of the surface play an important role in absorption 
through the gastrointestinal mucosa [35]. The surface area becomes 
larger as the particle size decreases so that most of the drug will be 
near the surface of the particle. In these conditions, drug release 
becomes faster. Larger particles have larger nuclei so more drugs 
can be packaged and diffuse slowly [38]. 
Some publications formulate polyphenol compounds, especially 
quercetin in the form of nanoparticles. Chitosan nanoparticles are 
formulated to improve the oral bioavailability of flavonoids [35]. The 
antioxidant activity of quercetin can be increased in the chitosan-alginate 
nanoparticle formula [39]. Polymer nanoparticles with routine active 
substances have been formulated using chitosan and TPP in the form of 
nanoparticles [40]. Nanoparticle formula using chitosan was detected 
stably in gastric fluid media, while the stability in simulated intestinal 
fluid media was only 20 % released and 80 % was still absorbed in 
chitosan nanoparticles. Positively charged nanoparticles are absorbed 
through mucoadhesive, polymeric nanoparticles tend to show high levels 
of drug release. This is very important in the oral administration route to 
ensure that no drug is released from preparation before reaching the 
systemic circulation [35]. 
Administration of ME-NPs has been shown to increase phagocytic 
index and phagocytic activity. Chitosan as the primary polymer in 
the formula gives different results compared to other test groups. 
Mechanisms related to the effectiveness of ME-NPs as 
immunomodulators still need to be studied further regarding drug 
delivery and other immunological activity parameters. Based on the 
theory, the positive charge of polymer particles helps to interact 
with the intestinal mucous membrane which helps in the release and 
absorption of active compounds. 
Chitosan has been proven in vitro and in vivo to increase drug 
absorption due to the mucoadhesive ability and tight junction 
opening in mucous cell membranes [17, 41]. The interaction of 
chitosan which is positively charged and the negative charge of 
mucin causes a long contact time between the drug and the 
absorption surface. This condition causes an increase in drug 
absorption. Chitosan nanoparticles have unique features in 
absorption, namely by M cells and follicles in lymphoid tissues that 
are connected to the intestine in the gastrointestinal system. After 
reaching the apical membrane of intestinal epithelial cells, most of 
the nanoparticles cross the enterocytes through transcellular 
transport. Nanoparticles enter the bloodstream or lymphatic vessels 
through exocytosis. Particles measuring less than 500 nm enter 
through endocytosis with mediators clathrin and caveolae. The ion 
or cationic layer of chitosan protects polymeric nanoparticles from 
endolysosomal degradation in enterocytes [35, 41]. 
CONCLUSION 
Meniran herbal ethanolic extract was successfully formulated into 
polymeric nanoparticles using chitosan-tripolyphosphate. Extracts 
in the nanoparticle formula produced a higher phagocytic index 
value and phagocytic activity of macrophages which was better than 
the unformulated extract. Evaluation of other parameters of 
immunomodulatory activity is needed to produce superior starting 
material as nano-herbal development. 
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